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a b s t r a c t
Cardiogenic shock represents the leading cause of death in hospitalized patients with acute
coronary syndromes. Immediate revascularization,  either percutaneous or surgical, cur-
rently represents the only intervention of proven beneﬁt. Despite the lack of such proof,
intraaortic balloon pump (IABP) and vasoactive drugs are typically used to improve hemo-
dynamic stability on top of revascularization.  Mechanical circulatory support devices
beyond IABP such as Impella, TandemHeart and venoarterial extracorporeal membrane
oxygenation (VA ECMO) are hemodynamically even more effective. Despite the lack of
proven survival beneﬁt, this technology might be lifesaving in case of profound hemody-
namic deterioration in the catheterization laboratory. We describe a case of profound
cardiac shock due to complicated coronary artery disease, recurrent cardiac arrest during
PCI, intraarrest PCI intra-aortic balloon pump insertion and successful resuscitation after
venoarterial ECMO placement. Complete revascularization was achieved following ECMO
insertion and patient was discharged home on day 29 with no neurological sequelae with
ejection fraction of 40%.
# 2014 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o.o.
All rights reserved.
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.1. Introduction
Cardiogenic shock represents the leading cause of death in
hospitalized patients with acute coronary syndromes. Imme-
diate revascularization, either percutaneous or surgical,
currently represents the only intervention with a randomized* Corresponding author at: Center for Intensive Internal Medicine, Un
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aortic balloon pump (IABP) and vasoactive drugs are typically
used to improve hemodynamic stability on top of revasculari-
zation [2,3]. Mechanical circulatory support devices beyond
IABP such as Impella, TandemHeart and venoarterial extra-
corporeal membrane oxygenation (VA ECMO) are hemody-
namically more effective and, despite the lack of proveniversity Medical Center, Zaloska 7, 1000 Ljubljana, Slovenia.
vier Urban & Partner Sp. z o.o. All rights reserved..
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strategy in patients with profound hemodynamic collapse [4–
11]. We herein report the case of a patient with cardiogenic
shock complicated by refractory cardiac arrest during percu-
taneous coronary intervention (PCI) in whom percutaneous VA
ECMO insertion in the catheterization laboratory proved to be
lifesaving.
2. Case report
A 52-year-old active smoker with hyperlipidemia but without
history of coronary artery disease was brought to the
community hospital by emergency prehospital team. His
complaint was severe dyspnea and chest pain escalating
during the last 3 days. Except for acetylsalicylic acid 100 mg
and ezetimibe 10 mg/simvastatin 20 mg, he was not taking any
regular medication. Electrocardiogram (ECG) recorded by the
prehospital unit revealed ST elevation in V1–3 and, notably,
elevation in aVR together with depression in V5–6 (Fig. 1a). An
evolving pulmonary edema was diagnosed and since it was
refractory to morphine, furosemide and oxygen, endotracheal
intubation was performed and mechanical ventilation initiat-
ed soon after hospital admission. Because of hypotension,
norepinephrine infusion was also added. Repeat ECG revealed
resolution of ST-elevation in precordial leads but not in aVR,
and ST-depression in several other leads (Fig. 1b). Cardiac
troponin T (TnT) was only slightly elevated (0.32 mmol/L,
normal <0.013 mmol/L). Our hospital was alerted for immedi-
ate coronary angiography and the patient was transported by
ambulance within 50 min.
On the admission to our hospital, transesophageal echo-
cardiography was immediately performed to exclude possible
mechanical defect (i.e. mitral chordae or papillary muscle
rupture). Apical akinesia and diffuse hypokinesia of ante-
rolateral wall with left ventricular ejection fraction below 30%
and signiﬁcant mitral regurgitation without ﬂail leaﬂet were
documented. The patient was then transported to the
catheterization laboratory. Despite norepinephrine and dobu-
tamine, initial aortic pressure was 100/75 and heart rate of
130 bpm. Coronary angiography revealed severe diffuse
obstructive coronary disease with eccentric 60% ostial left
main (LM) stenosis, occlusion of left anterior descending artery
(LAD) after the ﬁrst septal branch with some collaterals to the
distal vessel (Rentrop 1–2), occluded ﬁrst diagonal branch, long
90–95% ostial stenosis of medium sized ﬁrst obtuse marginal
branch, 99% stenosis of large second obtuse marginal branch
with TIMI 3 and proximal chronic total occlusion of the
dominant right coronary artery (RCA) with predominately left
to right collaterals (Fig. 2). Based on prehospital ECG and
echocardiography with evidence of apical akinesia/anterolat-
eral hypokinesia, LAD was considered as a culprit vessel. The
plan was to restore LAD patency and improve hemodynamic
status followed by PCI of second obtuse marginal. The patient
received unfractioned heparin according to activated clotting
time and JL 4 6 Fr guiding catheter was used to engage left
coronary artery without ventricularization of pressure tracing.
A standard working horse guide-wire (Advance, Abbott
Vascular) was passed across the occlusion with the support
of Minitrack 2.0 mm  15 mm balloon (Abbott Vascular).Following a few balloon inﬂations, patency of LAD with TIMI
1–2 was restored. Despite this, hemodynamic status further
deteriorated to pulseless electrical activity. Chest compression
was initiated, epinephrine boluses administered and norepi-
nephrine infusion increased. Effectiveness of chest compres-
sion was assured by continuous monitoring of the aortic
pressure. After approximately 5 min, spontaneous circulation
was restored. Intraaortic balloon pump (IABP) using 7.5 Fr 40 cc
linear balloon catheter (Maquet Getinge Group) was inserted
through the left femoral artery and epinephrine infusion
added to already existing vasopressor/inotropic support.
Transient hemodynamic stabilization was followed by recur-
rent cardiac arrest which was this time refractory to
conventional cardiac life support. During ongoing cardiopul-
monary resuscitation which only transiently restored sponta-
neous circulation, VA ECMO was implemented. In brief,
guiding catheter was removed from right femoral artery and
6 Fr sheath exchanged for 17 Fr arterial cannula after sequen-
tial dilatation using Seldinger technique. The tip of the arterial
cannula was placed at the aortic bifurcation. Anterogarde
puncture of ipsilateral superﬁcial femoral artery for sheath
insertion to prevent limb ischemia was, due to urgency of the
situation and lack of pulsative ﬂow, abandoned. A 21 Fr venous
cannula was inserted through the left femoral vein using the
same percutaneous technique. The tip was positioned at the
entry into the right atrium. VA ECMO (CardioHelp, Maquet
Getting Group) was started and ‘‘rpm’’ increased to 3600
resulting in 3.54 L/min retrograde aortic ﬂow. IABP was
maintained at 1:1 ratio. The total time from onset of refractory
cardiac arrest to VA ECMO ‘‘jump start’’ was 30–35 min.
Because of prolonged cardiac resuscitation and persistent
coma despite reestablishment of cerebral perfusion, cooling
using VA ECMO circuit was initiated to reach a target
temperature between 32 and 34 C [12]. Cardiac surgeon was
called to the catheterization laboratory and a decision was
made to proceed with emergency CABG. Since all operating
rooms were occupied, the patient was transiently transported
to cardiac intensive care unit. Epinephrine infusion could have
been discontinued and norepinephrine/dobutamine signiﬁ-
cantly reduced. Excessive urinary output (600 mL) was
documented already within initial 2 h. Arterial lactate, which
was within normal limits in referring hospital, increased to a
maximum of 9.5 mmol/L (Fig. 3). Cardiac troponin I (TnI) before
CABG was 3.99 mmol/L (normal <0.06 mmol/L). After 4 h in
intensive care unit, the patient was transported to the
operating room. Levosimendan infusion was started and VA
ECMO was replaced with conventional heart–lung machine
using the same cannulas. LAD was grafted by LIMA. Large
obtuse marginal and RCA were grafted by safenous vein grafts.
Since left ventricular function did not improve after CABG, VA
ECMO and IABP were re-started and the patient transferred to
intensive care unit. Arterial lactate normalized within 30 h
(Fig. 3) and urinary output was normal. TnI increased to a
maximum of 22.48 during the ﬁrst postoperative day.
Postoperative course was complicated by bleeding at the site
of arterial cannula requiring intervention on the second
postoperative day, malignant ventricular arrhythmias with
ventricular ﬁbrillation requiring coronary angiography to
conﬁrm grafts patency on day 3, nosocomial infections
requiring treatment with several antimicrobial drugs and
Fig. 1 – Prehospital electrocardiogram (a) and electrocardiogram after hospital admission, intubation, mechanical ventilation
and norepinephrine infusion.
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Fig. 2 – Immediate coronary angiography of the left (a) and
right (b) coronary artery.
Fig. 3 – Arterial lactate concentration during initial 30 h after
first presentation.
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darone. Left ventricular function gradually improved and
allowed successful weaning from ECMO on day 14 facilitated
by IABP which was removed on day 15. Mechanical ventilation
followed by tracheal extubation was discontinued on day 20.
The total duration of intensive care stay was 24 days. The
patient was discharged from our hospital 29 days after the
index event with normal neurocognitive status. Except for
limited area of akinesia of the apical part of inter-ventricular
septum, echocardiography revealed normalization of ejection
fraction and only non-signiﬁcant mitral regurgitation. Five
months after the index event, the patient is living his normal
life (NYHA) and has an ejection fraction of 40%.3. Discussion
We herein describe a previously healthy man with acute
coronary syndrome and very complex coronary disease
presenting with pulmonary edema followed by cardiogenic
shock and refractory cardiac arrest during PCI attempt. After
failure of advanced cardiac life support, VA ECMO was
lifesaving and allowed for urgent CABG, reversal of cardiogenic
shock within 24 h and bought time for myocardial recovery
following revascularization.
Looking retrospectively, the best solution for this patient
would have probably been immediate hemodynamic support
by IAPB or VA ECMO followed by complete surgical revascu-
larization without PCI attempt. The reason for hemodynamic
deterioration during PCI might have been accidental deep
engagement of the guiding catheter into the stenosed LM
during PCI or balloon withdrawal. Despite successful initial
resuscitation, cardiac arrest undoubtedly worsened already
existing cardiogenic shock which ultimately progressed to
refractory cardiac arrest. Despite the lack of randomized data,
we can speculate that this complication might have been
avoided by implementation of hemodynamic support prior to
PCI attempt [13,14] or if we immediately decided for
emergency CABG without PCI attempt.
After hemodynamic stabilization with VA ECMO, we were
faced with the dilemma regarding the timing of CABG since
‘‘acute heart team’’ in the catheterization laboratory felt that
further PCI attempts would not represent the optimal
revascularization option. At that point, one possibility was
to wait with CABG for few days to reverse cardiogenic shock by
ECMO and document neurological recovery after cardiac
arrest. However, since we suspected LAD occlusion to be
acute, such delay may have resulted in large, unreperfused
anterior infarction. Since peak TnI increased only to 22 mmol/L
after CABG, which is 10–20 times less what we usually
expected in such acute LAD occlusion, the infarct was either
largely aborted by timely CABG or LAD occlusion has not been
the culprit despite initial ECG, echocardiography and ability to
cross occlusion without dedicated CTO wire. Indeed, the
culprit might have been also large obtuse marginal branch
with spontaneous re-perfusion before coronary angiography.
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complex multi-vessel disease, the culprit lesion may not be
unequivocally identiﬁed, and in fact, multiple culprits are also
possible [15]. From the interventional point of view, however,
we believe that correct identiﬁcation of culprit lesion is
important since this lesion should be primary treated followed
by non-culprit lesions advised by the guidelines [15]. Complete
revascularization seems to be important also in cardiogenic
shock complicated by cardiac arrest which was the case in our
patient [15]. Since this could have been hardly achieved during
index PCI, emergency CABG was decided by the our ‘‘acute
heart team’’ and should not be forgotten as a potential solution
in the presence of complex coronary disease despite profound
hemodynamic collapse.
Nowadays, there is increasing evidence predominantly
coming from far east that refractory cardiac arrest, even in
the prehospital setting, may be successfully stabilized by VA
ECMO which buys time for subsequent revascularization with
remarkable 10–20% survival with good neurological outcome
[16,17]. In fact, such hyper-invasive strategy in patients with
out-of-hospital cardiac arrest and no return of spontaneous
circulation is currently being tested in the randomized fashion
[18]. If such catastrophic situation occurs in the cath laboratory
such as in our patient, immediate VA ECMO insertion can be
faster and more easily accomplished than either on the ﬁeld or
in emergency department [4–7]. Instead of surgical cut down,
percutaneous insertion of cannulas by interventional cardiolo-
gist without is rather straight forward and safe even in the
absence of pulsative ﬂow since X-ray may be used to control
position of the wire and advancement of ECMO cannulas even
during ongoing chest compression. It is very important to
emphasize, however, that delay between cardiac arrest and
‘‘jump start’’ by VA ECMO should be as short as possible because
this will reduce the severity of post-resuscitation brain injury
and post-resuscitation systemic inﬂammatory response lead-
ing to multiple organ dysfunction. Since pre-primed ECMO is
rarely available, ECMO priming should be performed in parallel
with insertion of arterial and venous cannulas by additional
team. Assist devices such as Impella, which is inserted into the
left ventricle and does not need oxygenator, are even more user
friendly [11]. We therefore believe that temporary circulatory
assist devices may in the near future become a standard of care
in ‘‘24-7’’ catheterization laboratories treating patients with
acute coronary syndromes. This would allow for hemodynamic
stabilization followed by PCI also in patients with profound
cardiogenic shock and cardiac arrest thereby providing a
realistic chance for survival [18,19].
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